Iteris (ITI) has had the highest return since January 1, 2024 by a small-cap US stock, returning 5,230.8%.
| ASSET | % RETURN |
|---|---|
Iteris (ITI) | 5,230.81% |
LENZ Therapeutics (LENZ) | 1,927.07% |
Fitell Corporation Ordinary Shares (FTEL) | 1,559.87% |
Dave (DAVE) | 958.4% |
Root (ROOT) | 948.27% |
Red Cat (RCAT) | 907.87% |
Nano Nuclear Energy Inc Common Stock (NNE) | 833.33% |
Dogness International Corp Class A (DOGZ) | 775.36% |
Quantum Computing (QUBT) | 556.41% |
Intuitive Machines (LUNR) | 474.9% |
Innodata (INOD) | 459.63% |
Chromadex (CDXC) | 423.94% |
Corvus Pharmaceuticals (CRVS) | 417.34% |
AudioEye (AEYE) | 409.93% |
Destiny Tech100 (DXYZ) | 408.73% |
Mesoblast (MESO) | 368.06% |
Hyliion (HYLN) | 362.65% |
ASP Isotopes Inc Common Stock (ASPI) | 360.77% |
Redwire (RDW) | 354.14% |
Willis Lease Finance (WLFC) | 339.29% |
Emergent Biosolutions (EBS) | 303.4% |
Cango (CANG) | 284.85% |
Harrow Health (HROW) | 284.41% |
Capricor Therapeutics (CAPR) | 280.78% |
Hippo (HIPO) | 274.15% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
